Insider Selling: USANA Health Sciences, Inc. (NYSE:USNA) Insider Sells 5,732 Shares of Stock

USANA Health Sciences, Inc. (NYSE:USNA) insider Joshua Foukas sold 5,732 shares of the business’s stock in a transaction on Wednesday, March 12th. The shares were sold at an average price of $32.54, for a total transaction of $186,519.28. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

USANA Health Sciences Stock Down 4.4 %

Shares of NYSE USNA opened at $29.04 on Friday. USANA Health Sciences, Inc. has a fifty-two week low of $27.71 and a fifty-two week high of $50.11. The firm’s 50-day simple moving average is $32.53 and its 200 day simple moving average is $35.90. The stock has a market cap of $548.91 million, a P/E ratio of 10.26, a P/E/G ratio of 0.93 and a beta of 0.98.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings data on Tuesday, February 25th. The company reported $0.64 earnings per share for the quarter, beating analysts’ consensus estimates of $0.49 by $0.15. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. The business had revenue of $213.61 million for the quarter, compared to analysts’ expectations of $208.82 million. On average, sell-side analysts anticipate that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current fiscal year.

Institutional Investors Weigh In On USANA Health Sciences

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Martingale Asset Management L P raised its position in USANA Health Sciences by 2.1% in the third quarter. Martingale Asset Management L P now owns 16,732 shares of the company’s stock worth $634,000 after acquiring an additional 340 shares in the last quarter. KBC Group NV raised its position in USANA Health Sciences by 96.6% in the third quarter. KBC Group NV now owns 1,056 shares of the company’s stock worth $40,000 after acquiring an additional 519 shares in the last quarter. R Squared Ltd bought a new stake in USANA Health Sciences in the fourth quarter worth about $28,000. Safe Harbor Fiduciary LLC bought a new stake in USANA Health Sciences in the third quarter worth about $30,000. Finally, Exchange Traded Concepts LLC raised its position in USANA Health Sciences by 11.3% in the fourth quarter. Exchange Traded Concepts LLC now owns 8,578 shares of the company’s stock worth $308,000 after acquiring an additional 869 shares in the last quarter. 54.25% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on USNA shares. DA Davidson reduced their price target on shares of USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating for the company in a report on Thursday, February 27th. StockNews.com cut shares of USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 14th. Finally, Sidoti cut shares of USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, February 18th.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.